Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

Because the new method can replace a large stretch of defective DNA with a healthy sequence, the same retron-based package can fix any combination of mutations within that stretch of DNA without ...

Beam Therapeutics recently announced that its BEAM-302 program received FDA orphan drug designation, alongside encouraging updates for its gene-editing therapies targeting rare diseases such as sickle ...

Biotech company Metagenomi (NASDAQ:MGX) is utilizing artificial intelligence chips from Amazon Web Services (AMZN) to enhance ...

Discover why Beam Therapeutics Inc.'s innovative base editing platform and strong pipeline could lead the SCD space. Click ...

Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some ...

You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. Feeling uneasy about the markets? On this episode of Trader Talk, Hennion and Walsh Asset Management ...

Biotech company 10x Genomics filed two lawsuits against rival Illumina in Delaware federal court on Tuesday, accusing ...

Discover Danaher Q3 2025 earnings call insights—revenue growth, margin expansion, and 2026 targets. Get key financial and market outlook.

Gene editing, led by CRISPR, is expanding rapidly beyond medical applications, offering new opportunities across various biotech industries. Technological breakthroughs are fueling acceleration and ...

As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in coming days, analysts and especially investors will keep their eyes on whether the ...